ANTINEOPLASTIC ACTION OF ANTIBIOTIC CHRYSOMALLIN.
D000818:Animals; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002279:Carcinoma 256, Walker; D002286:Carcinoma, Ehrlich Tumor; D002822:Choriocarcinoma; D006689:Hodgkin Disease; D008223:Lymphoma; D008228:Lymphoma, Non-Hodgkin; D051379:Mice; D009362:Neoplasm Metastasis; D009369:Neoplasms; D009374:Neoplasms, Experimental; D010600:Pharmacology; D051381:Rats; D012106:Research; D012510:Sarcoma 180; D012511:Sarcoma 37; D012513:Sarcoma, Experimental
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; CARCINOMA 256, WALKER; CARCINOMA, EHRLICH TUMOR; CHORIOCARCINOMA; EXPERIMENTAL LAB STUDY; HODGKIN'S DISEASE; LYMPHOSARCOMA; MICE; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; RATS; SARCOMA 180, CROCKER; SARCOMA 37; SARCOMA, EXPERIMENTAL